Update in IBD

Join the inflammatory bowel disease and surgery experts as they discuss novel therapies, the latest on FDA-approved biologics and biosimilars, and treatment strategies for IBD.

Saturday, March 25, 2017
7:30 AM -3 PM
MGM Grand Detroit
1777 Third Street, Detroit, MI 48226

Objectives

At the completion of the course, the participant will be able to:

  1. Summarize the emerging therapies for IBD, including biosimilars, ustekinumab and mongersen
  2. Understand the management of IBD in elderly patients
  3. Understand the indications for Small Intestinal and Multivisceral Transplant for Crohn’s; when to refer a patient
  4. Understand therapeutic drug monitoring, the use of drug levels and antibody testing in IBD

For more information call (248) 344-4147. For help with online registration, refer to our registration tip sheet.

Register Today

CCFA logo

Endorsed by CCFA

ACCREDITATION STATEMENT:
Henry Ford Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT:
Henry Ford Health System designates this live course for a maximum of 5.25 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT:

In Compliance with the ACCME Standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose relevant financial interests of their own or spouse or partners with any commercial interests and/or non-FDA approved use of a drug or a device that is included in the presentation.